3.9 Semi-field testing of the solitary bee Osmia bicornis (L., 1758) (Hymenoptera, Megachilidae) in flowering Phacelia tanacetifolia – Chances, improvements and limitations

Based on the proposed test design of the ICPPR non-Apis working group, a semi-field (tunnel) study was conducted with the solitary bee Osmia bicornis (L., 1758) in flowering Phacelia using tunnels. Untreated crop was used as a control, and the insect growth regulator fenoxycarb as a test item which is intended to be used as reference item for this study type. To improve the design and to enhance the informative value of such studies our method deviated in three points: placing the cocoons in the tubes of the nesting units, performing additional brood assessments in two to three day intervals and increasing the application rate of the test item.Overall the results indicated that the proposed test design is suitable to perform studies on O. bicornis in Phacelia under semi-field conditions.Data on the reproduction performance, brood termination and hatching rate of the progenies show low variability between the replicates in both treatment groups. No impact on the flight activity, mortality, reproduction performance and hatching success of the progenies was observed, but an increased brood termination rate of larvae produced within the first days after application was recorded; in particular, placing the cocoons in the tubes lead to higher proportions of nesting established females. Moreover, due to the assessment of the cell production in 2 to 3 day intervals, it is possible to analyse time dependent effects on the reproductive performance, brood termination and hatching rate which can be expected by the decreasing exposure in the course of the study. And finally, it is shown that fenoxycarb is not a suitable reference item for such studies.Based on the proposed test design of the ICPPR non-Apis working group, a semi-field (tunnel) study was conducted with the solitary bee Osmia bicornis (L., 1758) in flowering Phacelia using tunnels. Untreated crop was used as a control, and the insect growth regulator fenoxycarb as a test item which is intended to be used as reference item for this study type. To improve the design and to enhance the informative value of such studies our method deviated in three points: placing the cocoons in the tubes of the nesting units, performing additional brood assessments in two to three day intervals and increasing the application rate of the test item.Overall the results indicated that the proposed test design is suitable to perform studies on O. bicornis in Phacelia under semi-field conditions.Data on the reproduction performance, brood termination and hatching rate of the progenies show low variability between the replicates in both treatment groups. No impact on the flight activity, mortality, reproduction performance and hatching success of the progenies was observed, but an increased brood termination rate of larvae produced within the first days after application was recorded; in particular, placing the cocoons in the tubes lead to higher proportions of nesting established females. Moreover, due to the assessment of the cell production in 2 to 3 day intervals, it is possible to analyse time dependent effects on the reproductive performance, brood termination and hatching rate which can be expected by the decreasing exposure in the course of the study. And finally, it is shown that fenoxycarb is not a suitable reference item for such studies

Single versus double field rate: Do different rates of fenoxycarb in chronic Oomen bee brood feeding tests cause different effects sizes?

Background: EFSA (2013) recommends to modify the Oomen bee brood feeding test (Oomen et al., 19922) from an acute to a chronic feeding test, but proposals regarding the concentration of the reference item fenoxycarb in such trials are missing. For the chronic Oomen bee brood feeding ring-test (see Lückmann & Schmitzer 2014) the double field rate was used. Due to the lack of information about the effect size of the single field rate two separate bee brood feeding tests (following the method given by the ring-test protocol) were conducted: one in July 2013 (study 1) and one in April 2014 (study 2). The single and the double field rate of fenoxycarb were applied each at both times. As endpoints effects on brood termination rate (BTR) of marked eggs, young and old larvae, pupal mortality and colony development (i.e. number of brood cells and colony strength) were recorded and evaluated.Results: The chronic administration of the double field rate caused reproducible results whereas those of the single field rate were more variable. Distinct (i.e. ≥ 50%) and statistically significant increased BTRs of eggs were observed for the single rate in study 2 only, and for the double rate in both studies. Pupal mortality was statistically significantly increased at both rates in both studies and also bee brood and colony strength development was affected at both rates in both studies. Distinct dose-related differences between the two test rates were present for the BTRs of eggs in study 1 and for pupal mortality and colony development in study 2.Conclusion: The chronic feeding of the single rate of fenoxycarb did not cause reproducible, doserelated effects. Therefore it is recommend using the double field rate of fenoxycarb as the toxic reference item dose in chronic Oomen bee brood feeding studies as long as no further data are available on the effect size of the single rate.Keywords: honeybees, chronic Oomen bee brood feeding test, fenoxycarb, single rate, double rat

Organ Preservation in Rectal Cancer: The Patients' Perspective

Organ preservation after a clinical complete response to radiochemotherapy is currently one of the most discussed topics in the management of rectal cancer. However, the patients' perspective has only been poorly studied so far. In this multicenter study, we examined 49 patients with locally advanced rectal cancer. The willingness to participate in an organ preservation study and the acceptance of the associated aspects such as intensified radiochemotherapy protocols, the need for close follow-up examinations and local regrowth rates were assessed. Attitudes were correlated with baseline quality of life parameters and psychological scales for “fear of progression”, “locus of control”, “depression”, and the “willingness to take risks”. A total of 83% of patients would consider the deferral of surgery in case of a clinical complete response (cCR). Three monthly follow-up studies and a 25% local regrowth rate are considered acceptable by 95% and 94% respectively. While 41% would be willing to exchange cure rates for a non-operative treatment strategy, a potentially more toxic radiochemotherapy in order to increase the probability of a cCR was the aspect with the lowest acceptance (55%). Psychological factors, in particular “locus of control” and “willingness to take risks”, influenced patient preferences regarding most of the assessed parameters. While in general a broad acceptance of an organ-preserving treatment can be expected, patient preferences and concerns regarding different aspects of this strategy vary widely and require specific consideration during shared decision making

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Purpose: REQUITE aimed to establish a resource for multi-national validation of models and biomarkers that predict risk of late toxicity following radiotherapy. The purpose of this article is to provide summary descriptive data. Methods: An international, prospective cohort study recruited cancer patients in 26 hospitals in eight countries between April 2014 and March 2017. Target recruitment was 5300 patients. Eligible patients had breast, prostate or lung cancer and planned potentially curable radiotherapy. Radiotherapy was prescribed according to local regimens, but centres used standardised data collection forms. Pre-treatment blood samples were collected. Patients were followed for a minimum of 12 (lung) or 24 (breast/prostate) months and summary descriptive statistics were generated. Results: The study recruited 2069 breast (99% of target), 1808 prostate (86%) and 561 lung (51%) cancer patients. The centralised, accessible database includes: physician-(47,025 forms) and patient-(54,901) reported outcomes; 11,563 breast photos; 17,107 DICOMs and 12,684 DVHs. Imputed genotype data are available for 4223 patients with European ancestry (1948 breast, 1728 prostate, 547 lung). Radiation-induced lymphocyte apoptosis (RILA) assay data are available for 1319 patients. DNA (n = 4409) and PAXgene tubes (n = 3039) are stored in the centralised biobank. Example prevalences of 2-year (1-year for lung) grade >= 2 CTCAE toxicities are 13% atrophy (breast), 3% rectal bleeding (prostate) and 27% dyspnoea (lung). Conclusion: The comprehensive centralised database and linked biobank is a valuable resource for the radiotherapy community for validating predictive models and biomarkers. Patient summary: Up to half of cancer patients undergo radiation therapy and irradiation of surrounding healthy tissue is unavoidable. Damage to healthy tissue can affect short-and long-term quality-of-life. Not all patients are equally sensitive to radiation "damage" but it is not possible at the moment to identify those who are. REQUITE was established with the aim of trying to understand more about how we could predict radiation sensitivity. The purpose of this paper is to provide an overview and summary of the data and material available. In the REQUITE study 4400 breast, prostate and lung cancer patients filled out questionnaires and donated blood. A large amount of data was collected in the same way. With all these data and samples a database and biobank were created that showed it is possible to collect this kind of information in a standardised way across countries. In the future, our database and linked biobank will be a resource for research and validation of clinical predictors and models of radiation sensitivity. REQUITE will also enable a better understanding of how many people suffer with radiotherapy toxicity

Prometheus []

[english] Prometheus is an internet-based LMS (learning management system) which, on the basis of a didactic framework, and in the form of a virtual simulation of the situation in the outpatient clinic, is at the disposal of medical training. Adaptability, interactivity, reflection and discursiveness form the basic pedagogical framework of the platform. In the various areas of the virtual clinic, a variety of learning scenarios are imaged. In the varying outpatient departments, a case-based clinical picture can be developed or consolidated. In the linked virtual library there are systematic tutorials for consolidating knowledge, in the internet café asynchronic tutoring or collaborative learning can take place via a forum and email function. All scenes or platforms have an intuitive, uniform interface, graphically anchored navigation and on all scenes a help- function is provided in the form of a virtual expert. The consistently uniform artistic design allows one to immerse oneself in the virtual world of clinical thought. With the help of virtual reality, factual knowledge becomes active knowledge, the virtual but authentic patient merged with real experiences and contributing to the development of expertise. <br>[german] Prometheus ist ein internetbasierte LMS (learning management system), das basierend auf einem didaktischen Rahmenwerk, in Form einer virtuellen Simulation der klinischen Ambulanzsituation, der medizinischen Aus- und Weiterbildung zur Verfügung steht. Adaptivität, Interaktivität, Reflexion und Diskursivität bilden das pädagogische Grundgerüst der Plattform. In den verschiedenen Bereichen der virtuellen Klinik, sind verschiedene Lernszenarien abgebildet. Fallbasiert kann in den verschiedenen Ambulanzen ein Krankheitsbild erschlossen oder vertieft werden. In der angegliederten virtuellen Bibliothek befinden sich systematische Tutorials zur Vertiefung, im Internetcafe kann über eine Forum- und Email Funktion asynchrones Tutoring oder kollaboratives Lernen stattfinden. Alle Szenen der Plattform haben ein intuitives, einheitliches Interface, eine grafisch verankerte Navigation und auf allen Szenen steht eine Hilfefunktion in Form eines virtuellen Experten zur Verfügung. Die durchgängig einheitliche, künstlerische Gestaltung ermöglicht ein Eintauchen in die virtuelle Welt des klinischen Denkens. Faktenwissen wird durch die virtuelle Realität zu Handlungswissen, der virtuelle aber authentische Patient, verschmilzt mit realen Erfahrungen und trägt zur Entwicklung von Expertise bei